Head and Neck Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading
Cancer Deaths on the Decline (February 11, 2013)Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading
Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading
Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Combined Treatment Provides Benefit for Nasopharyngeal Cancer (February 22, 2012)Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading
Erbitux Approved for New Use in Head and Neck Cancer (November 18, 2011)The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent or metastatic squamous cell head and neck cancer. Head... Continue Reading
Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr. Cassileth’s bio Dr. Cassileth is a world-renowned... Continue Reading
HPV Vaccine Recommended for Boys (November 1, 2011)The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses (HPV) consist of more than 100 different viruses.... Continue Reading
Chemotherapy During Pregnancy Not Linked with Developmental Problems in Kids (October 4, 2011)According to a study presented at the 2011 European Multidisciplinary Cancer Congress, children born to women who received chemotherapy during pregnancy do not appear to have an increased risk of heart or cognitive problems. Since relatively few women... Continue Reading
Latest Head and Neck Cancer News By Stage
General Head and Neck Cancer
Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)
The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Combined Treatment Provides Benefit for Nasopharyngeal Cancer (February 22, 2012)Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading
Erbitux Approved for New Use in Head and Neck Cancer (November 18, 2011)The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent or metastatic squamous cell head and neck cancer. Head... Continue Reading
HPV Vaccine Recommended for Boys (November 1, 2011)The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses (HPV) consist of more than 100 different viruses.... Continue Reading
More General Head and Neck Cancer